7,488
Views
186
CrossRef citations to date
0
Altmetric
Original Article

Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations

, , &
Pages 1519-1530 | Accepted 25 Mar 2010, Published online: 04 May 2010

References

  • Kolendorf K, Bojsen J, Deekert T. Clinical factors influencing the absorption of 125 I-NPH insulin in diabetic patients. Horm Metab Res 1983;15:274-8
  • Thow JC, Johnson AB, Fulcher G, et al. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Diabet Med 1990;7:600-2
  • Thow JC, Home PD. Insulin injection technique: depth of injection is important. Br Med J 1990;301:3-4
  • Engstrom L. Technique of insulin injection: is it important?. Pract Diab 1994;11:39
  • Strauss K, De Gols H, Letondeur C, et al. The Second Injection Technique Event (SITE), May 2000, Barcelona Spain). Pract Diab Int 2002;19:17-21
  • Matsumura M, Monden Y, Nakatani T, et al. Improvement of glycemic control by reeducation in insulin injection technique. Diabetes 2007;56(S1): Abstract 0157-OR
  • Vaag A, Pedersen KD, Lauritzen M, et al. Intramuscular verse subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diab Med 1990;7:335-42
  • Owens DR, Coates PA, Luzio SD, et al. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 2000;23:813-19
  • Clauson PG, Linde B. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients. Diabetes Care 1995;18:986-91
  • Hildebrandt P, Sestoft L, Nielsen SL. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care 1983;6:459-62
  • Heinemann L. Variability of insulin absorption and insulin action. Diab Technol Ther 2002;4:673-82
  • Frid A, Gunnarsson R, Güntner P, et al. Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care 1988;11:41-5
  • Polak M, Beregszaszi M, Belarbi Ni, et al. Subcutaneous or intramuscular injections of insulin in children. Are we injecting where we think we are? Diabetes Care 1996;19:1434-6
  • Frid A, Lindén B. Where do lean diabetics inject their insulin? A study using computed tomography. Br Med J (Clin Res Ed) 1986;292:1638
  • Vaag A, Handberg A, Lauritzen M, et al. Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care 1990;13:74-6
  • Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, et al. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999;22:1621-5
  • Laurent A, Mistretta F, Bottigioli D, et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007;25:6423-30
  • Schwartz S, Hassman D, Shelmet J, et al. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 Gauge × 6 mm needle versus a 29 Gauge ×12.7 mm needle in obese patients with diabetes mellitus. Clin Ther 2004;26:1663-78
  • Hofman PL, Lawton SA, Peart JM, et al. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents. Diabet Med 2007;24:1400-5
  • Birkebaek NH, Solvig J, Hansen B, et al. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care 2008;31:e65; doi:10.2337/dc08-0977
  • Nordander C, Willner J, Hansson G. Skerfving influence of the subcutaneous fat layer, as measured by ultrasound, skinfold calipers and BMI, on the EMG amplitude. Eur J Appl Physiol 2003;89:514-19
  • Poland GA, Borrud A, Jacobson RM, et al. Determination of deltoid fat pad thickness, implications for needle length in adult immunization. JAMA 1997;277:1709-11
  • Cash CJC, Berman LH, Treece GM, et al. Two- and three-dimensional ultrasound in the development of a needle-free injection system. Br J Radiol 2004;77:236-42
  • Schou AJ, Thomsen K, Plomgaard AM, et al. Methodological aspects of high-frequency ultrasound of skin in children. Skin Res Technol 2004;10:200-6
  • Gniadecka M. Effects of ageing on dermal echogenicity. Skin Res Technol 2001;7:204-7
  • Smith L. Histologic characteristics and ultrastructure of ageing skin. Cutis 1989;43:414-24
  • Gniedecka M, Jemec GBE. Quantitative evaluation of chronological ageing and photo ageing in vivo: studies on skin echogenicity and thickness. Br J Derm 1998;139:815-21
  • Seidenari S, Giusti G, Bertoni L, et al. Thickness and echogenicity of the skin in children as assessed by 20-MHz ultrasound. Dermatology 2000;201:218-22
  • Burbridge BE. Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections. Can Assoc Radiol J 2007;58:72-5
  • Birkebaek NH, Johansen A, Slovig J. Cutis/subcutis thickness at insulin injection sites and localization of simulated insulin boluses in children with type 1 diabetes mellitus: need for individualization of injection technique?. Diabet Med 1998;15:965-71
  • Frid A, Linde B. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 1992;9:236-9
  • Hirsch LJ, Klaff LJ, Bailey TS, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010;26:1531-41
  • Kreugel G, Keers JC, Jongbloed A, et al. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes 2009;58(S1): Abstract 440-P
  • Strauss K, Hannet I, McGonigle J, et al. Ultra-short (5 mm) insulin needles: trial results and clinical recommendations. Pract Diab Int 1999;16:218-22

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.